http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210132535-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2440-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-165 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate | 2020-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20210132535-A |
| titleOfInvention | Composition for diagnosing SARS-CoV-2 comprising agents detecting the level of acetylation of transforming growth factor β-induced protein |
| abstract | The present invention relates to a composition for diagnosing severe acute respiratory syndrome virus 2 (SARS-CoV-2) infection comprising an agent for measuring the acetylation level of transforming growth factor β-induced protein (TGFBIp). It relates to a composition for diagnosing SARS-CoV-2 infection, comprising an agent for measuring the level of acetylation in lysine (K676), which is the 676th amino acid. The composition of the present invention can very accurately diagnose SARS-CoV-2 infection by measuring the acetylation level of TGFBIp, and furthermore, the severity of the infection can be diagnosed through the analysis of the acetylation level of TGFBIp, so SARS-CoV-2 It can be very useful for diagnosis. |
| priorityDate | 2020-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 602.